AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Nirvana Life Sciences Inc Regulatory Filings 2021

Oct 26, 2021

47227_rns_2021-10-25_fc9bbf44-e348-419d-bd35-bf1869db454c.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

==> picture [612 x 127] intentionally omitted <==

October 22, 2021

British Columbia Securities Commission

P.O. Box 10142, Pacific Centre 9[TH] Floor – 701 West Georgia Street Vancouver, B.C. V7Y 1L2

Ontario Securities Commission

20 Queen Street West, 22nd Floor Toronto, ON M5H 3S8

Dear Sirs:

Re: Endocan Solutions Inc. (the “Company”) Notice Pursuant to National Instrument 51‐102 ‐ Change of Auditor

As required by the National Instrument 51‐102 and in connection with our proposed engagement as auditor of the Company, we have reviewed the information contained in the Company's Notice of Change of Auditor, dated October 13, 2021 and agree with the information contained therein, based upon our knowledge of the information relating to the said notice and of the Company at this time.

Yours very truly,